Mike Gietl is an Executive Director with J.P. Morgan’s Life Sciences banking team, working with startup through small-cap companies in Minnesota and Canada. He focuses on companies in the medical device, pharmaceutical (generic and specialty), biosimilar, and tools and diagnostic spaces. Mike has over 17 years of experience at J.P. Morgan, including structuring and implementing wide-ranging credit transactions and managing relationships with a variety of manufacturing and industrial corporations, large research universities and private colleges. He has worked with taxable and tax-exempt financing structures, syndications and participations for these entities. He also brings expertise in treasury management for companies looking for efficient ways to manage their operations. Mike is based in Minneapolis.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.